Let's talk medical research

Today, 70% of the 18 million adults in the U.S. experience moderate-to-severe symptoms. Nearly half of people with eczema report that they "often" or "always" feel frustrated by their disease. One-third report that they spend up to three hours per day treating their disease.

A few years ago, we wrote a blog series for ACRP in which we focused on patient centricity in clinical trial design, recruitment, and execution. Over the next few months, we’ll be taking a second look at those blog posts, sharing updated versions on our own blog. Here’s an update to the first in that series.

An estimated 5.8 million people in the United States have been diagnosed with Alzheimer's disease. As the millions of patients and caregivers around the country know too well, there is not a treatment option that slows or stops disease progression.

Living with a chronic illness or other condition can take up a significant piece of a patient's time. Though clinical trials can be beneficial to patients, recruitment efforts have to compete with many other products and services that can offer a patient support.

With patients waiting for new and better treatments and companies waiting for results, delays in clinical trials are far from ideal. And yet, here at Antidote, we receive calls and emails every day from researchers who are missing their trial’s deadlines because they’re having trouble finding patients to take part.

While there is no recommended diet for autoimmune hepatitis, diet considerations related to weight management and alcohol consumption may make an impact on both symptoms and disease progression. Following a healthy diet and talking with your doctor about alcohol consumption can help you avoid complications related to obesity, reduce weight gain from common steroid treatments, and avoid ...

As a clinical trial sponsor, you don't have time to waste. Running a clinical trial for one day can cost up to $37,000 by some estimations. Delays in new treatments hurt patients waiting for better options, too.

Today, nearly 25 million people in the United States are living with asthma. For 5 to 10% of those living with asthma, symptoms such as wheezing and shortness of breath aren't well managed by their current treatments.

Today, study teams have a variety of clinical trial recruitment tools at their disposal to find the right patients for their studies. As anyone involved in the patient recruitment process knows, enrolling patients into studies isn't a one-size-fits-all solution. Complex protocols in particular can make recruiting patients particularly challenging – and make using a varied approach more important.

If you live with asthma, you may still have trouble with symptoms even on your regular medication. That’s why asthma clinical trials explore new potential treatments for asthma.